Balchem (BCPC) to Release Earnings on Thursday

Balchem (NASDAQ:BCPCGet Free Report) is projected to post its Q1 2025 quarterly earnings results before the market opens on Thursday, April 24th. Analysts expect the company to announce earnings of $1.12 per share and revenue of $245.70 million for the quarter.

Balchem (NASDAQ:BCPCGet Free Report) last posted its earnings results on Friday, February 21st. The basic materials company reported $1.03 EPS for the quarter, missing analysts’ consensus estimates of $1.11 by ($0.08). Balchem had a net margin of 13.47% and a return on equity of 11.37%. The firm had revenue of $240.00 million for the quarter, compared to the consensus estimate of $239.96 million. On average, analysts expect Balchem to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Balchem Stock Performance

Balchem stock opened at $156.92 on Tuesday. The company’s 50-day moving average price is $164.79 and its 200-day moving average price is $167.54. Balchem has a twelve month low of $137.69 and a twelve month high of $186.03. The company has a market cap of $5.11 billion, a PE ratio of 39.93, a price-to-earnings-growth ratio of 4.41 and a beta of 0.75. The company has a quick ratio of 1.16, a current ratio of 1.99 and a debt-to-equity ratio of 0.19.

Analyst Upgrades and Downgrades

BCPC has been the topic of a number of research analyst reports. Sidoti upgraded shares of Balchem to a “hold” rating in a report on Tuesday, February 25th. StockNews.com downgraded Balchem from a “buy” rating to a “hold” rating in a report on Tuesday, February 25th. Finally, HC Wainwright reiterated a “buy” rating and set a $190.00 target price on shares of Balchem in a report on Monday, February 24th.

View Our Latest Stock Analysis on BCPC

Balchem Company Profile

(Get Free Report)

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.

Further Reading

Earnings History for Balchem (NASDAQ:BCPC)

Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.